Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance

Clinical trial NCT07178457 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07178457
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cutaneous T Cell Lymphoma (CTCL)Brentuximab Vedotin

Start date: 2025-11-01
Primary completion: 2032-11-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.